March 21st 2025, 7:00pm
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
March 20th 2025, 9:00pm
Dr. Sara M. Tolaney discussed HER2-positive breast cancer, highlighting key trials, evolving treatment strategies, and the potential for improved outcomes.
March 20th 2025, 8:00pm
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
March 20th 2025, 7:05pm
Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according to Dr. Kevin Kalinsky.
March 19th 2025, 9:00pm
Gene expression testing helps determine chemotherapy needs for HR+ breast cancer, optimizing treatment and reducing unnecessary toxicity.
March 18th 2025, 8:01pm
Genetic and genomic testing guide breast cancer risk assessment and treatment, as discussed by Dr. Mark Robson at the Miami Breast Cancer Summit.
March 18th 2025, 1:00pm
Dr. Debu Tripathy discusses recent research on the use of circulating tumor DNA in metastatic breast cancer care.
March 16th 2025, 2:00pm
CURE spoke with Kelly Grosklags of Conversations With Kelly at the Miami Breast Cancer Conference.
March 15th 2025, 6:00pm
Dr. Kevin Kalinsky covers the gamut of the current treatment landscape for patients with HER2-negative breast cancer, highlighting recent advancements.
March 12th 2025, 3:00pm
Dr. Kandace P. McGuire discusses how targeted axillary staging differs from traditional methods of staging in patients undergoing breast cancer treatment.
Venclexta And Azacitidine Fail to Improve MDS Survival
What Does a Blood Cancer Diagnosis Mean?
What Are Genitourinary Cancers, and How Are They Treated?
Empower Yourself: What to Know After a Prostate Cancer Diagnosis